## Clinical Assessment This patient presents with a **vocal cord lesion confirmed as squamous cell carcinoma** with no distant metastases on staging imaging. The key clinical feature is that the lesion is **localized to the vocal cord** (early-stage disease). ## Management Algorithm for Early Laryngeal Carcinoma ```mermaid flowchart TD A[Laryngeal SCC diagnosed]:::outcome --> B{Stage?}:::decision B -->|Early stage<br/>T1-T2, N0| C[Transoral laser<br/>microsurgery TLM]:::action B -->|Locally advanced<br/>T3-T4 or N+| D[Concurrent chemoRT<br/>or laryngectomy]:::action C --> E[Voice preservation<br/>Single modality]:::outcome D --> F{Resectable?}:::decision F -->|Yes| G[Laryngectomy ±<br/>neck dissection]:::action F -->|No| H[Concurrent chemoRT]:::action ``` ## Why TLM is the Next Step **Key Point:** For **T1–T2 vocal cord carcinomas** (early stage, no nodal involvement), transoral laser microsurgery is the gold standard first-line treatment. It offers: 1. **Single-modality cure** — complete excision with histologic margins in one procedure 2. **Voice preservation** — maintains laryngeal function better than radiotherapy 3. **Outpatient feasibility** — shorter hospital stay, faster recovery 4. **No long-term toxicity** — avoids radiation side effects (xerostomia, late stenosis) 5. **Salvage options preserved** — if recurrence occurs, radiation or repeat surgery remains available **High-Yield:** TLM is preferred over external beam radiation for **early vocal cord cancers** because it achieves equivalent cure rates (85–95% local control) with superior functional outcomes [cite:Robbins 10e Ch 16]. **Clinical Pearl:** The absence of nodal disease (N0 on imaging) and the localized nature of the lesion make this a candidate for organ-preservation surgery rather than laryngectomy. ## Why Other Options Are Incorrect See distractor analysis below. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.